Dutch Court Invalidates Pfizer Lipitor Patent
A Dutch court has invalidated a patent for Pfizer Inc.'s Lipitor, but generics drugmaker Ranbaxy Laboratories Inc. is still blocked from launching a generic version of the blockbuster cholesterol drug....To view the full article, register now.
Already a subscriber? Click here to view full article